Activation of glucuronide prodrugs by...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 31/70 (2006.01) A61K 31/7036 (2006.01) A61K 38/47 (2006.01) A61P 35/00 (2006.01) C07H 15/22 (2006.01)

Patent

CA 2081281

Activation of Glucuronide Prodrugs By Ligand-.beta.-Glucuronidase Conjugates for Chemotherapy Abstract of the Disclosure A method for enhancing the specificity of chemotherapy is disclosed. A monoclonal antibody that can bind antigens preferentially expressed on the surface of malignant cells is used to form a conjugate with the enzyme .beta.-glucuronidase. Glucuronide analogues of therapeutic drugs, possessing reduced toxicity and enhanced efficacy compared with the parent compound, are administered subsequent to the administration of the .beta.-glucuronidase-anitbody conjugate such that the glucuronide analogues are enzymatically converted to therapeutic agents at malignant cells that are able to bind .beta.-glucuronidase-monoclonal antibody conjugates.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Activation of glucuronide prodrugs by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Activation of glucuronide prodrugs by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activation of glucuronide prodrugs by... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1772469

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.